WO2007014338A3 - Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease - Google Patents
Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease Download PDFInfo
- Publication number
- WO2007014338A3 WO2007014338A3 PCT/US2006/029449 US2006029449W WO2007014338A3 WO 2007014338 A3 WO2007014338 A3 WO 2007014338A3 US 2006029449 W US2006029449 W US 2006029449W WO 2007014338 A3 WO2007014338 A3 WO 2007014338A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cardiovascular disease
- methods
- susceptibility
- single nucleotide
- nucleotide polymorphisms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Abstract
The present invention provides SNPs, polymorphic variants, and haplotypes associated with cardiovascular disease. The invention also provides methods for detecting the SNPs, polymorphic variants, and haplotypes. The invention also provides methods for determining an individual's genotype with respect to one or more polymorphisms and/or haplotypes associated with cardiovascular disease. The invention further provides methods of determining whether an individual has or is susceptible to development or occurrence of a cardiovascular disease or event. The methods are useful for providing diagnostic and/or prognostic information, selecting therapeutic regimens, etc. The invention further provides reagents and kits for practicing the methods.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06788815A EP1907589A4 (en) | 2005-07-26 | 2006-07-26 | Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease |
US12/019,651 US20080233582A1 (en) | 2005-07-26 | 2008-01-25 | Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease |
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70276005P | 2005-07-26 | 2005-07-26 | |
US60/702,760 | 2005-07-26 | ||
US70321905P | 2005-07-27 | 2005-07-27 | |
US60/703,219 | 2005-07-27 | ||
US70871905P | 2005-08-15 | 2005-08-15 | |
US60/708,719 | 2005-08-15 | ||
US74240705P | 2005-12-05 | 2005-12-05 | |
US60/742,407 | 2005-12-05 | ||
EP06012722 | 2006-06-21 | ||
EPEP06012722.2 | 2006-06-21 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/019,651 Continuation-In-Part US20080233582A1 (en) | 2005-07-26 | 2008-01-25 | Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2007014338A2 WO2007014338A2 (en) | 2007-02-01 |
WO2007014338A8 WO2007014338A8 (en) | 2007-04-12 |
WO2007014338A3 true WO2007014338A3 (en) | 2010-05-20 |
Family
ID=37683999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/029449 WO2007014338A2 (en) | 2005-07-26 | 2006-07-26 | Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1907589A4 (en) |
WO (1) | WO2007014338A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2267153A1 (en) * | 2009-05-26 | 2010-12-29 | Université Claude Bernard Lyon 1 | Identification of netrin-1 receptor unc5c gene mutation in solid cancers |
AU2021239861A1 (en) * | 2020-03-16 | 2022-10-06 | The University Of North Carolina At Chapel Hill | Compositions and methods for the selective detection of tumor-derived viral DNA |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030113725A1 (en) * | 2000-04-17 | 2003-06-19 | Small Kersten M. | Alpha-2 adrenergic receptor polymorphisms |
US20040014059A1 (en) * | 1999-01-06 | 2004-01-22 | Choong-Chin Liew | Method for the detection of gene transcripts in blood and uses thereof |
US20050026169A1 (en) * | 2002-12-20 | 2005-02-03 | Applera Corporation | Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001024681A2 (en) * | 1999-08-09 | 2001-04-12 | University Of Utah Research Foundation | Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same |
WO2001059064A2 (en) * | 2000-01-31 | 2001-08-16 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
US6812339B1 (en) * | 2000-09-08 | 2004-11-02 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
EP1562973A4 (en) * | 2002-10-17 | 2007-01-03 | Decode Genetics Ehf | Susceptibility gene for myocardial infarction |
-
2006
- 2006-07-26 WO PCT/US2006/029449 patent/WO2007014338A2/en active Application Filing
- 2006-07-26 EP EP06788815A patent/EP1907589A4/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040014059A1 (en) * | 1999-01-06 | 2004-01-22 | Choong-Chin Liew | Method for the detection of gene transcripts in blood and uses thereof |
US20030113725A1 (en) * | 2000-04-17 | 2003-06-19 | Small Kersten M. | Alpha-2 adrenergic receptor polymorphisms |
US20050026169A1 (en) * | 2002-12-20 | 2005-02-03 | Applera Corporation | Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
Non-Patent Citations (2)
Title |
---|
HARA ET AL.: "Identification of two cDNAs for human actin-related proteins (Arps) that have remarkable similarity to conventional actin.", BIOCHIMICA BIOPHYSICA ACTA, vol. 1522, no. 2, 2001, pages 130 - 133, XP004326977, DOI: doi:10.1016/S0167-4781(01)00315-3 * |
See also references of EP1907589A4 * |
Also Published As
Publication number | Publication date |
---|---|
EP1907589A4 (en) | 2010-11-24 |
WO2007014338A8 (en) | 2007-04-12 |
WO2007014338A2 (en) | 2007-02-01 |
EP1907589A2 (en) | 2008-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005082110A3 (en) | Haplotype markers for diagnosing susceptibility to immunological conditions | |
WO2010103292A3 (en) | A genotyping tool for improving the prognostic and clinical management of ms patients | |
WO2006063704A3 (en) | Single nucleotide polymorphism (snp) associated to type ii diabetes | |
CA2499084A1 (en) | Actn3 genotype screen for athletic performance | |
WO2008137121A3 (en) | Methods for detecting an increased risk for coronary heart disease | |
WO2008017002A3 (en) | Polymorphisms in genes affecting cns disorders and uses thereof | |
NZ598009A (en) | Genetic markers associated with risk of diabetes mellitus | |
WO2006089238A3 (en) | Multiplex assays for inferring ancestry | |
WO2008076856A3 (en) | Reagents and methods for detecting cyp2d6 polymorphisms | |
NZ612799A (en) | Improved method and kit for determining severity and progression of periodontal disease | |
WO2006099259A3 (en) | Novel missense mutations and single nucleotide polymorphisms in the rabphillin-3a-like gene and uses thereof | |
WO2003046203A3 (en) | Genetic markers associated with desirable and undesirable traits in horses, methods of identifying and using such markers | |
WO2005112568A3 (en) | Haplotype markers and methods of using the same to determine response to treatment | |
WO2007014338A3 (en) | Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease | |
WO2003054166A3 (en) | Nucleotide polymorphisms associated with osteoarthritis | |
WO2006063703A3 (en) | Single nucleotide polymorphism (snp) associated to type ii diabetes | |
WO2006053955A3 (en) | Method and kit for detecting a risk of essential arterial hypertension | |
EP2297351A1 (en) | A combination of risk alleles associated with autism | |
ATE431431T1 (en) | DIAGNOSIS OF UNIPARENTAL DISOMIA USING SINGEL NUCLEOTIDE POLYMORPHISMS | |
Ide et al. | Genetic and expression analyses of FZD3 in schizophrenia | |
WO2008048902A3 (en) | Methods of using single nucleotide polymorphisms in the il23r gene to predict or diagnose inflammatory bowel disease | |
WO1997043446A3 (en) | Diagnostic method and apparatus for detecting a predisposition to certain disease states, especially osteoporosis, based on polymorphism in an il-6 gene | |
Nievergelt et al. | Admixture mapping as a gene discovery approach for complex human traits and diseases | |
WO2008131367A3 (en) | Methods of diagnosing alzheimer's disease and markers identified by set association | |
US20140255930A1 (en) | Materials and Methods Related to Dopamine Dysregulation Disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006788815 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |